Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial

References

• Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012;6:CD005996
   Google Scholar
• Hayashi T, Kitaya K, Tada Y, et al. Single curettage endometrial biopsy injury in the proliferative phase improves reproductive outcome of subsequent in vitro fertilization-embryo transfer cycle in infertile patients with repeated embryo implantation failure. Clin Exp Obstet Gynecol 2013;40:323–6
   PubMed Web of Science ®Google Scholar
• Yoshii N, Hamatani T, Inagaki N, et al. Successful implantation after reducing matrix metalloproteinase activity in the uterine cavity. Reprod Biol Endocrinol 2013;11:37
   PubMed Web of Science ®Google Scholar
• Gizzo S, Capuzzo D, Zicchina C, et al. Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1-2 activity inhibition? J Assist Reprod Genet 2014;31:261–8
   PubMed Web of Science ®Google Scholar
• Engmann L, DiLuigi A, Schmidt D, et al. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertil Steril 2008;89:554–61
   PubMed Web of Science ®Google Scholar
• Artini PG, Volpe A, Angioni S, et al. A comparative randomized study of three different progesterone support of the luteal phase following IVF/ET program. J Endocrinol Invest 1995;18:51–6
   PubMed Web of Science ®Google Scholar
• Elgindy EA, El-Haieg DO, Mostafa MI, Shafiek M. Does luteal estradiol supplementation have a role in long agonist cycles? Fertil Steril 2010;93:2182–8
   PubMed Web of Science ®Google Scholar
• Ceyhan ST, Basaran M, Kemal Duru N, et al. Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study. Fertil Steril 2008;89:1827–30
   PubMed Web of Science ®Google Scholar
• Litta P, D’Agostino G, Conte L, et al. Anti-Müllerian hormone trend after laparoscopic surgery in women with ovarian endometrioma. Gynecol Endocrinol 2013;29:452–4
   PubMed Web of Science ®Google Scholar
• Saccardi C, Cosmi E, Borghero A, et al. Comparison between transvaginal sonography, saline contrast sonovaginography and magnetic resonance imaging in the diagnosis of posterior deep infiltrating endometriosis. Ultrasound Obstet Gynecol 2012;40:464–9
   PubMed Web of Science ®Google Scholar
• Patrelli TS, Berretta R, Gizzo S, et al. CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate. Fertil Steril 2011;95:393–6
   PubMed Web of Science ®Google Scholar
• Litta P, Cosmi E, Saccardi C, et al. Outpatient operative polypectomy using a 5 mm-hysteroscope without anaesthesia and/or analgesia: advantages and limits. Eur J Obstet Gynecol Reprod Biol 2008;139:210–14
   PubMed Web of Science ®Google Scholar
• Saccardi C, Conte L, Fabris A, et al. Hysteroscopic enucleation “in toto” of submucous type 2 myomas: long term follow up in women affected by menorrhagia. J Minim Invasive Gynecol 2014;21:426–30
   PubMed Web of Science ®Google Scholar
• Colacurci N, De Franciscis P, Mollo A, et al. Small-diameter hysteroscopy with Versapoint versus resectoscopy with a unipolar knife for the treatment of septate uterus: a prospective randomized study. J Minim Invasive Gynecol 2007;14:622–7
   PubMed Web of Science ®Google Scholar
• Saccardi C, Gizzo S, Ludwig K, et al. Endometrial polyps in women affected by levothyroxine-treated hypothyroidism – histological features, immunohistochemical findings, and possible explanation of etiopathogenic mechanism: a pilot study. Biomed Res Int 2013;2013:503419
   PubMed Web of Science ®Google Scholar
• Litta P, Conte L, De Marchi F, et al. Pregnancy outcome after hysteroscopic myomectomy. Gynecol Endocrinol 2014;30:149–52
   PubMed Web of Science ®Google Scholar
• Ciavattini A, Di Giuseppe J, Stortoni P, et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int 2013;2013:173184
   PubMedGoogle Scholar
• Litta P, Leggieri C, Conte L, et al. Monopolar versus bipolar device: safety, feasibility, limits and perioperative complications in performing hysteroscopic myomectomy. Clin Exp Obstet Gynecol 2014;41:335–8
   PubMed Web of Science ®Google Scholar
• Gizzo S, Patrelli TS, Rossanese M, et al. An update on diabetic women obstetrical outcomes linked to preconception and pregnancy glycemic profile: a systematic literature review. Sci World J 2013;2013:254901
   Google Scholar
• World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge, UK: Cambridge University Press; 1999
   Google Scholar
• Gizzo S, Andrisani A, Esposito F, et al. Ovarian reserve test: an impartial means to resolve the mismatch between chronological and biological age in the assessment of female reproductive chances. Reprod Sci 2014;21:632–9
   PubMed Web of Science ®Google Scholar
• Fatemi HM, Popovic-Todorovic B, Papanikolaou E, et al. An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 2007;13:581–90
   PubMed Web of Science ®Google Scholar
• Fatemi HM. The luteal phase after 3 decades of IVF: what do we know? Reprod Biomed Online 2009;19:4331
   PubMedGoogle Scholar
• Lin H, Li Y, Li L, et al. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study. Eur J Obstet Gynecol Reprod Biol 2013;167:171–5
   PubMed Web of Science ®Google Scholar
• Serna J, Cholquevilque JL, Cela V, et al. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial. Fertil Steril 2008;90:2190–5
   PubMed Web of Science ®Google Scholar
• Drakakis P, Loutradis D, Vomvolaki E, et al. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer. Gynecol Endocrinol 2007;23:645–52
   PubMed Web of Science ®Google Scholar
• Smitz J, Bourgain C, Van Waesberghe L, et al. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. Hum Reprod 1993;8:40–5
   PubMed Web of Science ®Google Scholar
• Lewin A, Benshushan A, Mezker E, et al. The role of estrogen support during the luteal phase of in vitro fertilization-embryo transplant cycles: a comparative study between progesterone alone and estrogen and progesterone. Fertil Steril 1994;62:121–5
   PubMed Web of Science ®Google Scholar
• Farhi J, Weissman A, Steinfeld Z, et al. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 2000;73:761–6
   PubMed Web of Science ®Google Scholar
• Gizzo S, Andrisani A, Noventa M, et al. Recombinant LH supplementation during IVF cycles with GnRH-antagonist protocols in estimated poor responders: what is the best daily-dose and timing to administer it? A cross-matched pilot study. Mol Med Rep 2014, in press
   Google Scholar
• Minaretzis D, Alper MM, Oskowitz SP, et al. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells. Am J Obstet Gynecol 1995;172:1518–25
   PubMed Web of Science ®Google Scholar
• Tavaniotou A, Devroey P. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod Biomed Online 2006;13:326–30
   PubMed Web of Science ®Google Scholar